PRECIPIO INC (PRPO) Stock Fundamental Analysis

NASDAQ:PRPO • US74019L6020

22.73 USD
-0.92 (-3.89%)
Last: Feb 25, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

PRPO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. The financial health of PRPO is average, but there are quite some concerns on its profitability. PRPO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • PRPO had negative earnings in the past year.
  • PRPO had a positive operating cash flow in the past year.
  • In the past 5 years PRPO always reported negative net income.
  • PRPO had negative operating cash flow in 4 of the past 5 years.
PRPO Yearly Net Income VS EBIT VS OCF VS FCFPRPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • PRPO has a worse Return On Assets (-5.93%) than 69.31% of its industry peers.
  • Looking at the Return On Equity, with a value of -9.12%, PRPO is in line with its industry, outperforming 44.55% of the companies in the same industry.
Industry RankSector Rank
ROA -5.93%
ROE -9.12%
ROIC N/A
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
PRPO Yearly ROA, ROE, ROICPRPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

  • The Gross Margin of PRPO (44.82%) is better than 73.27% of its industry peers.
  • In the last couple of years the Gross Margin of PRPO has grown nicely.
  • The Profit Margin and Operating Margin are not available for PRPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
PRPO Yearly Profit, Operating, Gross MarginsPRPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • PRPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PRPO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PRPO has more shares outstanding
  • PRPO has a worse debt/assets ratio than last year.
PRPO Yearly Shares OutstandingPRPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
PRPO Yearly Total Debt VS Total AssetsPRPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -2.79, we must say that PRPO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -2.79, PRPO is not doing good in the industry: 85.15% of the companies in the same industry are doing better.
  • PRPO has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • The Debt to FCF ratio of PRPO (1.87) is better than 81.19% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that PRPO is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.06, PRPO is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.87
Altman-Z -2.79
ROIC/WACCN/A
WACC8.7%
PRPO Yearly LT Debt VS Equity VS FCFPRPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that PRPO should not have too much problems paying its short term obligations.
  • PRPO has a Current ratio (1.27) which is comparable to the rest of the industry.
  • PRPO has a Quick Ratio of 1.10. This is a normal value and indicates that PRPO is financially healthy and should not expect problems in meeting its short term obligations.
  • PRPO has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.1
PRPO Yearly Current Assets VS Current LiabilitesPRPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 59.49% over the past year.
  • Looking at the last year, PRPO shows a very strong growth in Revenue. The Revenue has grown by 30.95%.
  • The Revenue has been growing by 42.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)59.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.6%
Revenue 1Y (TTM)30.95%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%29.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRPO Yearly Revenue VS EstimatesPRPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRPO Yearly EPS VS EstimatesPRPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PRPO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRPO Price Earnings VS Forward Price EarningsPRPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRPO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 67.53
EV/EBITDA N/A
PRPO Per share dataPRPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PRPO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRECIPIO INC

NASDAQ:PRPO (2/25/2026, 8:00:01 PM)

22.73

-0.92 (-3.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-12
Inst Owners19.25%
Inst Owner Change-12.64%
Ins Owners12%
Ins Owner Change-0.86%
Market Cap39.78M
Revenue(TTM)22.80M
Net Income(TTM)-1.25M
Analysts82.86
Price TargetN/A
Short Float %0.26%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF 67.53
P/OCF 45
P/B 2.89
P/tB 15.35
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.34
FCFY1.48%
OCF(TTM)0.51
OCFY2.22%
SpS13.03
BVpS7.86
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.93%
ROE -9.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.82%
FCFM 2.58%
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.87
Debt/EBITDA N/A
Cap/Depr 21.15%
Cap/Sales 1.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.1
Altman-Z -2.79
F-Score6
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)15.96%
Cap/Depr(5y)23.27%
Cap/Sales(3y)1.67%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.95%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%29.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.1%
OCF growth 3YN/A
OCF growth 5YN/A

PRECIPIO INC / PRPO FAQ

What is the fundamental rating for PRPO stock?

ChartMill assigns a fundamental rating of 3 / 10 to PRPO.


Can you provide the valuation status for PRECIPIO INC?

ChartMill assigns a valuation rating of 1 / 10 to PRECIPIO INC (PRPO). This can be considered as Overvalued.


How profitable is PRECIPIO INC (PRPO) stock?

PRECIPIO INC (PRPO) has a profitability rating of 2 / 10.